NCCN Clinical Practice Guidelines in Oncology: Acute myeloid leukemia, version 3.2019 Guidelines


Authors: Tallman, M. S.; Wang, E. S.; Altman, J. K.; Appelbaum, F. R.; Bhatt, V. R.; Bixby, D.; Coutre, S. E.; De Lima, M.; Fathi, A. T.; Fiorella, M.; Foran, J. M.; Hall, A. C.; Jacoby, M.; Lancet, J.; LeBlanc, T. W.; Mannis, G.; Marcucci, G.; Martin, M. G.; Mims, A.; O'Donnell, M. R.; Olin, R.; Peker, D.; Perl, A.; Pollyea, D. A.; Pratz, K.; Prebet, T.; Ravandi, F.; Shami, P. J.; Stone, R. M.; Strickland, S. A.; Wieduwilt, M.; Gregory, K. M.; Hammond, L.; Ogba, N.
Title: NCCN Clinical Practice Guidelines in Oncology: Acute myeloid leukemia, version 3.2019
Abstract: Acute myeloid leukemia (AML) is the most common form of acute leukemia among adults and accounts for the largest number of annual deaths due to leukemias in the United States. Recent advances have resulted in an expansion of treatment options for AML, especially concerning targeted therapies and low-intensity regimens. This portion of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for AML focuses on the management of AML and provides recommendations on the workup, diagnostic evaluation and treatment options for younger (age <60 years) and older (age ≥60 years) adult patients. © 2019 Harborside Press. All rights reserved.
Keywords: immunohistochemistry; chronic myelomonocytic leukemia; gene mutation; united states; cytarabine; drug megadose; molecular genetics; antigen expression; cytogenetics; practice guideline; intensive care; myelodysplastic syndrome; leukemia cell; remission; allogeneic hematopoietic stem cell transplantation; immunophenotyping; flt3 ligand; anthracycline; hla typing; hla antigen; induction chemotherapy; cd33 antigen; gemtuzumab ozogamicin; leukemia remission; acute myeloid leukemia; next generation sequencing; human; article; prognostic assessment; venetoclax
Journal Title: Journal of the National Comprehensive Cancer Network
Volume: 17
Issue: 6
ISSN: 1540-1405
Publisher: Harborside Press  
Date Published: 2019-06-01
Start Page: 721
End Page: 749
Language: English
DOI: 10.6004/jnccn.2019.0028
PUBMED: 31200351
PROVIDER: scopus
DOI/URL:
Notes: Article -- Export Date: 2 August 2019 -- Source: Scopus
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Martin Stuart Tallman
    649 Tallman
Related MSK Work